James F. Pingpank

University of Pittsburgh Medical Center

Papers

1

Total Citations

21

H-Index

1

About

James F. Pingpank is a surgical oncologist whose work has significantly advanced the treatment of liver malignancies, particularly through the refinement of hepatic artery infusion (HAI) chemotherapy. His research focuses on improving surgical techniques and outcomes for patients with isolated unresectable colorectal liver metastases and intrahepatic cholangiocarcinoma. A key contribution is his demonstration that robotic-assisted placement of HAI pumps is a safe and feasible alternative to traditional laparotomy, reducing the morbidity associated with pump implantation while maintaining therapeutic efficacy. This work, detailed in his 2016 paper with 21 citations, addresses a critical need for less invasive approaches in regional liver-directed therapy. Pingpank’s impact extends beyond this single study; his broader portfolio of highly cited research has helped establish HAI chemotherapy as a viable option for patients with liver-dominant disease, influencing clinical guidelines and surgical practice. By merging technical innovation with patient-centered outcomes, he has provided a pathway for more accessible, effective treatment of complex hepatic tumors, earning recognition as a leader in hepatobiliary surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach
21 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of Pittsburgh Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago